Malignant Cervical Neoplasm — Trials

Malignant Cervical Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 506
Recruiting: 280
Ph III recruiting: 34
Growth YoY: −11.9%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.7%
Trials / 1,000 deaths: 121.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06639191	[177Lu]Lu-AKIR001 First-in-human Study(AKIR001)	recruiting	Early Phase 1	15	Karolinska University HospitalOTHER	1	Jan 30, 2026	clinicaltrials
NCT07341360	Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei(Pseudovax)	recruiting	Early Phase 1	10	Oslo University HospitalOTHER	1	Jan 14, 2026	clinicaltrials